Exiqon As (EXQNF) 1.1200 $EXQNF
qPCR and dPCR Markets (Instruments, Reagents, Software/Services, Clinical and Research Markets) Report 2013-2018
M2 - Tue Nov 18, 9:24AM CST
Research and Markets (http://www.researchandmarkets.com/research/tv8xlw/qpcr_and_dpcr) has announced the addition of the "qPCR and dPCR Markets (Instruments, Reagents, Software/Services, Clinical and Research Markets)" report to their offering. Real time qPCR is considered the gold standard for accurate, sensitive, and fast quantification of nucleic acid sequences. PCR technologies, specifically qPCR (quantitative PCR) and digital PCR (dPCR) show significant promise for growth. qPCR is mainly a workhorse in the research laboratory, while dPCR is helping to push the potential for diagnostic applications due to its sensitivity, precision, robustness and reproducibility. qPCR has been established for a broad range of applications including gene expression, genotyping, pathogen detection, DNA methylation analysis. qPCR is increasingly being used in the medical diagnostic arena for diagnosis of bacterial disease, detection of antibiotic resistance, diagnosis of infectious disease and quantification of bacterial load. It is also used to detect genetic abnormalities and cancer mutations. qPCR-based diagnostic tests are expected to expand in the coming years. dPCR provides absolute measurement of copies and would seem to be the next logical step in PCR evolution. dPCR partitions the sample and reaction components into hundreds or thousands of reaction chambers to count the presence or absence of molecules. It provides greatly improved sensitivity in the detection of rare mutations and sequences. This technology will become increasingly important in the clinical application of PCR. Segments Include: - Clinical Market for qPCR - Research Market for qPCR - Clinical Market for dPCR - Research Market for dPCR - qPCR Instruments - qPCR Reagents - qPCR Software and Services - dPCR Instruments - dPCR Reagents - dPCR Software and Services Some of the market drivers influencing participation: - A global aging population - An increase in the number of population affected by chronic medical conditions - Advancements in gene detection and technologies - The increasing role of diagnostics in home health and remote patient care - Personalized medicine - Advancements next generation sequencing and multi-gene approaches Challenges facing those in the market, including: - Development financial, time investment risk - Uncertain regulatory environment - Cost to patient may limit accessibility in many regions - Economic uncertainty: patients are likely to decline advanced testing in times of hardship - New technologies more difficult to develop Some of the issues and trends affecting this market are: - BRIC Involvement - qPCR and Robotics - Lab-on-a-Chip Devices - Molecular Testing Reimbursement Companies profiles in this report include: - Abbott Laboratories - Affymetrix - Aglient Technologies - Analytik Jena AG - Becton Dickinson - BioFire Diagnostics - bioMerieux - Bio-Rad Laboratories - Cephid - Denville Scientific - Eppendorf AG - Exiqon A/S - Fluidigm - Illumina - Kyratec - Life Techologies - Promega - Qiagen - RainDance Technologies - Roche - Sacace Biotechnologies - Takaro Bio - Thermo Fisher Scientific - WaferGen Biosystems For more information visit http://www.researchandmarkets.com/research/tv...r_and_dpcr
ABT: 46.09 (+0.87)
qPCR and dPCR Markets (Instruments, Reagents, Software/Services, Clinical and Research Markets) Report 2013-2018
M2 - Tue Nov 18, 9:24AM CST
Research and Markets (http://www.researchandmarkets.com/research/tv8xlw/qpcr_and_dpcr) has announced the addition of the "qPCR and dPCR Markets (Instruments, Reagents, Software/Services, Clinical and Research Markets)" report to their offering. Real time qPCR is considered the gold standard for accurate, sensitive, and fast quantification of nucleic acid sequences. PCR technologies, specifically qPCR (quantitative PCR) and digital PCR (dPCR) show significant promise for growth. qPCR is mainly a workhorse in the research laboratory, while dPCR is helping to push the potential for diagnostic applications due to its sensitivity, precision, robustness and reproducibility. qPCR has been established for a broad range of applications including gene expression, genotyping, pathogen detection, DNA methylation analysis. qPCR is increasingly being used in the medical diagnostic arena for diagnosis of bacterial disease, detection of antibiotic resistance, diagnosis of infectious disease and quantification of bacterial load. It is also used to detect genetic abnormalities and cancer mutations. qPCR-based diagnostic tests are expected to expand in the coming years. dPCR provides absolute measurement of copies and would seem to be the next logical step in PCR evolution. dPCR partitions the sample and reaction components into hundreds or thousands of reaction chambers to count the presence or absence of molecules. It provides greatly improved sensitivity in the detection of rare mutations and sequences. This technology will become increasingly important in the clinical application of PCR. Segments Include: - Clinical Market for qPCR - Research Market for qPCR - Clinical Market for dPCR - Research Market for dPCR - qPCR Instruments - qPCR Reagents - qPCR Software and Services - dPCR Instruments - dPCR Reagents - dPCR Software and Services Some of the market drivers influencing participation: - A global aging population - An increase in the number of population affected by chronic medical conditions - Advancements in gene detection and technologies - The increasing role of diagnostics in home health and remote patient care - Personalized medicine - Advancements next generation sequencing and multi-gene approaches Challenges facing those in the market, including: - Development financial, time investment risk - Uncertain regulatory environment - Cost to patient may limit accessibility in many regions - Economic uncertainty: patients are likely to decline advanced testing in times of hardship - New technologies more difficult to develop Some of the issues and trends affecting this market are: - BRIC Involvement - qPCR and Robotics - Lab-on-a-Chip Devices - Molecular Testing Reimbursement Companies profiles in this report include: - Abbott Laboratories - Affymetrix - Aglient Technologies - Analytik Jena AG - Becton Dickinson - BioFire Diagnostics - bioMerieux - Bio-Rad Laboratories - Cephid - Denville Scientific - Eppendorf AG - Exiqon A/S - Fluidigm - Illumina - Kyratec - Life Techologies - Promega - Qiagen - RainDance Technologies - Roche - Sacace Biotechnologies - Takaro Bio - Thermo Fisher Scientific - WaferGen Biosystems For more information visit http://www.researchandmarkets.com/research/tv...r_and_dpcr
ABT: 46.09 (+0.87)
